Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about CYBN
Recent news which mentions CYBN
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
March 30, 2024
Tickers
CMND
CMPS
CYBN
FLHLF
Tags
Psychedelics
CMND
MDXXF
From
Benzinga
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Tickers
CLNN
CYBN
LIFE
Tags
Stocks to Buy
NASDAQ:CLNN,NASDAQ:LIFE,NYSEAMERICAN:CYBN
Market News
From
InvestorPlace
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Psychedelics
CMND
DRUG
From
Benzinga
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
March 13, 2024
Tickers
CMPS
CYBN
MNMD
Tags
Breakthrough Therapy Drug
Biotech
Psychedelics
From
Benzinga
3 High-Potential Penny Stocks to Turn $1000 into $1 million
March 10, 2024
Tickers
CYBN
GOEV
JOB
Tags
NASDAQ:GOEV,NYSEMKT:CYBN,NYSEMKT:JOB
Market News
Uncategorized
From
InvestorPlace
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Benzinga
SPRC
Global
From
Benzinga
Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
February 16, 2024
Tickers
CYBN
NEWS
Tags
Markets
Opinion
News
From
Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
Tickers
ATAI
AWKNF
CMND
CYBN
Tags
Legal
MYCOF
MNMD
From
Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
January 27, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Top Stories
psilocybin therapies
IXHL
From
Benzinga
FDA Green Lights Cybin's Psychedelic Clinical Study Assessing Generalized Anxiety
January 23, 2024
Tickers
CYBN
NEWS
Tags
Market News
Cannabis
Psychedelic/Assisted Therapies
From
Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Psychedelics Investing
PHRRF
Market News
From
Benzinga
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
January 12, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
DRUG
Psychedelics
CMND
From
Benzinga
30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond
January 10, 2024
Tickers
CYBN
ENVB
NEWS
NUMIF
Tags
TRIL
Psychedelics Influencers
Markets
From
Benzinga
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
January 09, 2024
Tickers
CYBN
NEWS
Tags
Psychedelics
Global
Psychedelic/Assisted Therapies
From
Benzinga
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
January 06, 2024
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Penny Stocks
FDA
Rick Doblin
From
Benzinga
Psychedelic Stock Gainers And Losers From January 1, 2024
January 01, 2024
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Movers
CYBN
CMPS
From
Benzinga
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
December 14, 2023
Tickers
BIIB
CYBN
SUPN
Tags
Market News
SUPN
Stocks to Buy
From
InvestorPlace
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Psychedelics
DRUG
CMND
From
Benzinga
Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
December 03, 2023
Tickers
CYBN
Tags
News
Management
CYBN
From
Benzinga
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
November 24, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
CYBN
CMPS
News
From
Benzinga
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
November 23, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Movers
CYBN
CMPS
From
Benzinga
Analyst Expectations for Cybin's Future
November 17, 2023
Tickers
CYBN
Tags
CYBN
BZI/AAR
Benzinga
From
Benzinga
Expedia To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Friday
November 17, 2023
Tickers
A
ADI
CMAX
CYBN
Tags
PT Changes
CMAX
CYBN
From
Benzinga
Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals
November 15, 2023
Tickers
CYBN
Tags
CYBN
Psychedelics
Earnings
From
Benzinga
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
November 12, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
IXHL
HUGE
MNMD
From
Benzinga
Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal
November 10, 2023
Tickers
CYBN
Tags
Market News
Psychedelics Financing
Financing
From
Benzinga
Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
November 06, 2023
Tickers
ATAI
CMPS
CYBN
DEA
Tags
Markets
ENVB
CYBN
From
Benzinga
Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
November 01, 2023
Tickers
CYBN
Tags
News
CYBN
Markets
From
Benzinga
Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More
October 29, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Contracts
Rumors
TSLA
From
Benzinga
Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents
October 26, 2023
Tickers
CYBN
DMTTF
Tags
United States Patent and Trademark Office (USPTO)
DMTTF
Markets
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.